NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from…
New analysis of ZORYVE foam 0.3% demonstrates reduction in signs and symptoms of seborrheic dermatitis in individuals with diverse skin…
MUNICH, Sept. 10, 2025 /PRNewswire/ -- AVATR made a high-profile appearance at the 2025 Munich Auto Show (IAA), showcasing multiple star…
BERLIN, Sept. 10, 2025 /PRNewswire/ -- TCL, a global leader in consumer electronics and the world's No. 1 Mini LED…
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX…
CHANGSHA, China, Aug. 4, 2025 /PRNewswire/ -- Hunan TV's Mango TV program Singer 2025 is redefining global cultural exchange, using…
SHANGHAI, July 30, 2025 /PRNewswire/ -- From July 26 to 28, the 2025 World Artificial Intelligence Conference (WAIC) convened in Shanghai…
Key Takeaways Two lifestyle interventions in U.S. POINTER improved cognition in older adults at risk of cognitive decline. A structured…
Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase…
JERICHO, N.Y., June 26, 2025 /PRNewswire/ -- Global consulting firm J.S. Held is honored to be recognized by Chambers and…